BOSTON (Reuters) – Lindblad Expeditions on Thursday said it named two independent directors backed by activist investment firm ValueAct Capital, which owns a nearly 10% stake in the adventure cruise company, to its board. New York-based Lindblad appointed Thom... More »
NEW YORK (Reuters) – Investor Jeffrey Ubben, already betting there is money to be made from coaxing corporations into being better citizens, gained an ally on Tuesday when BlackRock Inc chief Laurence Fink told companies to tackle climate change or face his wr... More »
NEW YORK (Reuters) – Citigroup Inc (C.N) will give ValueAct Capital more access to its books and board of directors, signaling that the bank and the activist hedge fund are deepening their relationship roughly a year after ValueAct first invested in Citi. The ... More »
FILE PHOTO – A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo ValueAct Capital raised its stake in Valeant Pharmaceuticals International Inc, in a move that co... More »
Jeffrey Ubben, Founder & CEO at ValueAct Capital, speaks on the Reuters Newsmaker event ‘The Future of Shareholder Activism’ in Manhattan, New York, U.S., February 22, 2017. REUTERS/Andrew Kelly Jeffrey Ubben, the chief executive officer of activist investor V... More »
